The vagus nerve is the primary neural link between the brain and the heart. It carries the parasympathetic signals that slow heart rate, modulate cardiac rhythm, and influence blood pressure. When vagus nerve function is disrupted, whether through excessive activation, insufficient tone, or structural damage, the cardiovascular consequences can range from benign fainting episodes to clinically significant arrhythmias. This article covers the specific mechanisms by which vagus nerve problems affect heart health, what the current research shows, and what treatment options exist.
How the Vagus Nerve Controls Heart Rate
The vagus nerve exerts continuous inhibitory control over the heart’s intrinsic pacemaker, the sinoatrial (SA) node. At rest, vagal tone keeps heart rate well below what the SA node would produce on its own (approximately 100 beats per minute without any neural input). This tonic vagal braking is why a healthy resting heart rate sits between 60 and 80 bpm in most adults.
The mechanism is direct: postganglionic vagal fibres release acetylcholine onto muscarinic M2 receptors on SA node cells. This opens potassium channels, hyperpolarising the pacemaker cells and slowing their firing rate. The vagus also acts on the atrioventricular (AV) node, slowing conduction between the atria and ventricles. These effects are fast, operating within a single heartbeat, which is why vagal responses to stimuli like bearing down or cold water on the face produce immediate and measurable heart rate changes.
Heart rate variability (HRV), the beat-to-beat fluctuation in heart rate, is largely a reflection of vagal activity. Higher HRV generally indicates stronger vagal tone and more flexible autonomic regulation. Low HRV has been consistently associated with increased cardiovascular risk, including higher mortality after myocardial infarction, greater susceptibility to arrhythmias, and worse outcomes in heart failure. HRV measurement has become a standard research tool and is increasingly used in clinical risk stratification.
Vasovagal Syncope
Vasovagal syncope (neurocardiogenic syncope) is the most common form of fainting and the most familiar example of vagus nerve dysfunction affecting the heart. It occurs when a reflex arc triggers an abrupt increase in vagal output to the heart and a simultaneous withdrawal of sympathetic tone to the blood vessels. The result is a combination of bradycardia (slowed heart rate) and vasodepression (drop in blood pressure), causing insufficient blood flow to the brain and loss of consciousness.
Common triggers include prolonged standing, heat exposure, emotional stress, pain, and the sight of blood. The reflex appears to involve mechanoreceptors in the left ventricle that detect vigorous contraction against an under-filled chamber, sending afferent signals through the vagus nerve to the brainstem, which then produces the paradoxical vagal surge.
Vasovagal syncope is classified into subtypes based on the predominant mechanism: cardioinhibitory (primarily heart rate drop), vasodepressor (primarily blood pressure drop), or mixed. Tilt table testing with continuous heart rate and blood pressure monitoring can help identify which subtype a patient has, which matters for treatment selection. Patients with the cardioinhibitory subtype, where the heart rate drops dramatically or even pauses for several seconds, have historically been the most difficult to manage.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,684 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- HRV biofeedback
- Polyvagal-informed therapy
- Somatic therapy
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
Cardioneural Ablation: A New Approach
Cardioneural ablation (also called cardioneuroblation or CNA) is an emerging catheter-based procedure that targets the cardiac autonomic ganglia, clusters of neurons embedded in fat pads on the surface of the heart that serve as relay stations for vagal input. By selectively ablating these ganglia, the procedure aims to reduce excessive vagal influence on the heart without severing the vagus nerve itself.
Data from the US Multicenter CNA Registry, published in the Journal of Cardiovascular Electrophysiology in 2025, reported outcomes for patients with functional bradycardia and vasovagal syncope who underwent cardioneural ablation. The results showed significant reductions in syncope recurrence and improvements in heart rate parameters. The procedure is typically guided by high-frequency stimulation mapping to identify the ganglia before ablation.
Cardioneural ablation remains investigational and is not yet widely available. It is being studied as an alternative to permanent pacemaker implantation in younger patients with cardioinhibitory vasovagal syncope who would otherwise face decades of device-dependent management. Early results are promising, but long-term durability data and larger randomised trials are still needed.
Bradycardia and Heart Block
Excessive vagal tone can cause clinically significant bradycardia (heart rate below 60 bpm with symptoms). Athletes commonly have resting bradycardia from high vagal tone, which is physiological and asymptomatic. Pathological vagal bradycardia is different: it produces symptoms such as fatigue, dizziness, exercise intolerance, and syncope because the heart rate fails to increase appropriately with activity or drops too low at rest.
The vagus nerve can also cause transient heart block by slowing AV node conduction. First-degree AV block (prolonged PR interval) from high vagal tone is common and usually benign. Higher degrees of vagally mediated AV block, where conducted beats are dropped, can cause syncope and may require pacemaker implantation if symptoms are severe and recurrent.
Distinguishing vagally mediated bradycardia from intrinsic conduction disease is clinically important because the treatment approach differs. Vagally mediated bradycardia typically resolves with atropine (which blocks vagal acetylcholine) and worsens with vagal manoeuvres. Intrinsic conduction disease does not improve with atropine and is more likely to require permanent pacing.
Reduced Vagal Tone and Cardiovascular Risk
While excessive vagal activity causes syncope and bradycardia, insufficient vagal tone poses different cardiovascular risks. Reduced cardiac vagal tone, reflected in low HRV, is associated with increased sympathetic dominance and heightened cardiovascular risk. This pattern is common in conditions including heart failure, post-myocardial infarction, diabetes (through autonomic neuropathy), obesity, chronic stress, and ageing.
The ATRAMI study (Autonomic Tone and Reflexes After Myocardial Infarction) demonstrated that low HRV and reduced baroreflex sensitivity after heart attack were independent predictors of cardiac mortality. Subsequent research has consistently confirmed that vagal withdrawal, meaning reduced parasympathetic influence on the heart, is a marker of and contributor to adverse cardiac outcomes.
The mechanisms linking low vagal tone to cardiovascular risk include unchecked sympathetic activation (promoting arrhythmias, vasoconstriction, and platelet aggregation), loss of the anti-inflammatory effects of the vagal cholinergic pathway, and impaired baroreflex buffering of blood pressure fluctuations.
Atrial Fibrillation and the Vagus Nerve
The relationship between the vagus nerve and atrial fibrillation (AF) is complex. Vagally mediated AF typically occurs in younger, otherwise healthy individuals and tends to start during rest, sleep, or after meals, when vagal tone is highest. The mechanism involves vagal shortening of the atrial effective refractory period, which creates the electrophysiological conditions favouring re-entrant circuits and AF initiation.
This vagally mediated pattern is distinct from adrenergically mediated AF, which occurs during exercise or stress. The distinction matters because beta-blockers, which are first-line therapy for adrenergic AF, can worsen vagal AF by further enhancing parasympathetic tone. Patients with vagal AF may respond better to disopyramide or flecainide, which have vagolytic properties.
Paradoxically, the ganglionated plexi that are targets of cardioneural ablation are also being investigated as ablation targets in AF treatment. Pulmonary vein isolation combined with ganglionated plexus ablation has shown improved outcomes in some studies, though results have been inconsistent across trials.
Improving Cardiac Vagal Tone
For individuals with low vagal tone, several evidence-based approaches can improve cardiac vagal function. Aerobic exercise is the most consistently supported intervention, with regular moderate-intensity exercise producing measurable increases in resting HRV and baroreflex sensitivity. Slow-paced breathing at approximately 6 breaths per minute maximises respiratory sinus arrhythmia and has been shown to improve HRV acutely and, with regular practice through HRV biofeedback protocols, chronically.
Transcutaneous auricular vagus nerve stimulation (taVNS) is under investigation for its effects on cardiac autonomic function. Clinical trials are evaluating whether taVNS can improve HRV and reduce arrhythmia burden, though evidence remains preliminary. Implanted vagus nerve stimulation is also being studied for heart failure, with the ANTHEM-HFrEF trial reporting improvements in cardiac function markers, though results have been mixed across different VNS approaches and targets.
For diagnosing vagus nerve-related cardiac problems, standard tools include 12-lead ECG, Holter monitoring, tilt table testing, and autonomic function testing including HRV analysis and baroreflex sensitivity measurement. These tests help distinguish vagal cardiac dysfunction from other causes and guide appropriate treatment.
The vagus nerve’s role in heart health is one part of a much larger story about how this nerve influences every major organ system. If you want to understand the full picture, from cardiac regulation to gut function to immune modulation, the My Vagus Nerve & Me eBook covers the science comprehensively. Get My Vagus Nerve & Me eBook and learn how your vagus nerve shapes your cardiovascular health and overall wellbeing.




